Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

Src dimerization

Financiado

Cerrado

Activation of Src kinases through dimerization suggests novel therapeutic opport...

Activation of Src kinases through dimerization suggests novel therapeutic opportunities c-Src, the first proto-oncogene to be identified, controls many aspects of tumor biology including the capacity of the cancer cells to multiply, survive, and metastasize. We recently discovered that c-Src forms dimers and that dim... ver más

31/05/2023

MEDICAL UNIVERSITY...

183K€

Presupuesto del proyecto: 183K€

Líder del proyecto

MEDICAL UNIVERSITY SOFIA No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2023-05-31

MSCA-IF-2019: Individual Fellowships

I+D

Cerrada hace 5 años

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

MEDICAL UNIVERSITY SOFIA

182.72K€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

PID2019-104914RB-I00 EL EXTREMO DESORDENADO-MIRISTOILADO Y OTROS MECANISMOS NO CA... 182K€ Cerrado

RTI2018-096658-B-I00 DISTRIBUCION ESPACIAL Y DIMERIZACION DE ERK: IMPLICACIONES E... 345K€ Cerrado

RTKPalm Modulating and Profiling Receptor Tyrosine Kinase S palmitoy... 183K€ Cerrado

KARMA From the understanding of KRAS RAF membrane dynamics to new... 2M€ Cerrado

SAF2016-75991-R PAPEL DE LOS DOMINIOS ADAPTADORES SH2 Y SH3 DE C-SRC EN LA M... 121K€ Cerrado

SAF2009-09254 PAPEL CATALITICO/ADAPTADOR DE SRC EN DIFERENCIACION LACTOGEN... 224K€ Cerrado

Duración del proyecto: 37 meses Fecha Inicio: 2020-04-03
Fecha Fin: 2023-05-31

Líder del proyecto

MEDICAL UNIVERSITY SOFIA No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 183K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto c-Src, the first proto-oncogene to be identified, controls many aspects of tumor biology including the capacity of the cancer cells to multiply, survive, and metastasize. We recently discovered that c-Src forms dimers and that dimerization is essential for the activity of the enzyme. This represents a significant paradigm shift in our understanding of the biology of Src family kinases, which until recently were assumed to function as monomeric proteins. The discovery that c-Src functions as a dimer creates the basis for development of a novel class therapeutics in principle based on disruption of Src dimerization. Our preliminary data indicate that such dimerization inhibitors have dramatic anti-tumor activity, suggesting that the proposed research may lead to development of an effective anti-cancer therapy. The project goal is to accomplish the following specific objectives: 1. To determine the efficacy of inhibition of Src myristoylation and dimerization for treatment of cancer; 2. To develop competitive inhibitors of Src dimerization and activity. The project will also create opportunities of boosting the research and innovation capacity of Europe, for obtaining IPRs, commercialization, and setting new collaborations with top US research institutions and companies. The proposal is intended as a career development fellowship that is designed to facilitate my reintegration into the EU science and to further my career towards a leading independent research position. I am confident that the quality and excellence of science produced and the new research and complementary skills obtained during the fellowship will serve as a cornerstone for my future career advancement and mark the beginning of my new laboratory and research program.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores